SCSL Health Acquired By LumiraDx
SCSL Health are pleased to announce that they have been acquired by LumiraDx as of 8th April 2016.
The acquisition celebrates the coupling of SCSL Health’s anticoagulation management system (INRstar) with LumiraDx’s proven clinical integration platform, population health analytics and reporting capabilities. This means that SCSL Health will have more resource and capacity to develop and improve their anticoagulation offering.
Both businesses share a vision to achieve better health outcomes and choice for patients as well as improved efficacy for healthcare providers.
It will be business as usual for all of SCSL Healths customers with their team remaining the same with founder and Medical Director Dr Mark Sullivan, Clinical Director Dr Robert Treharne-Jones and Managing Director Michael Barritt joining the new board. We are excited about the benefits this development will bring to our current anticoagulation business and opportunities for further innovation towards improved health, social and financial outcomes on a scalable platform across a range of long term conditions.